Zentalis Pharmaceuticals, Inc. (ZNTL) DCF Valuation

Zentalis Pharmaceuticals, Inc. (ZNTL) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Zentalis Pharmaceuticals, Inc. (ZNTL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore Zentalis Pharmaceuticals, Inc. (ZNTL) financial outlook with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate Zentalis' intrinsic value and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -46.7 -117.9 -164.0 -219.9 -275.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .2 .5 1.4 1.4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -46.8 -118.1 -164.6 -221.3 -276.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 82.4 338.5 339.9 437.4 482.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .4 2.6 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 -4.4 -7.0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 4.3 8.7 11.6 11.2 14.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.4 -.8 -6.1 -2.5 -.6 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -5.53 -5.53 -5.53 -5.53 -5.53 -5.53 -5.53 -5.53 -5.53 -5.53
EBITAT -46.9 -118.5 -164.3 -220.8 -292.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -43.0 -115.1 -164.7 -217.1 -294.7 -14.9 .0 .0 .0 .0
WACC, % 11.21 11.21 11.21 11.21 11.21 11.21 11.21 11.21 11.21 11.21
PV UFCF
SUM PV UFCF -13.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -13
Net Debt 15
Equity Value -29
Diluted Shares Outstanding, MM 65
Equity Value Per Share -0.44

What You Will Get

  • Real ZNTL Financial Data: Pre-filled with Zentalis Pharmaceuticals’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Zentalis’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Zentalis Pharmaceuticals, Inc. (ZNTL).
  • WACC Tool: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to ZNTL.
  • Customizable Forecast Assumptions: Easily adjust growth rates, capital expenditures, and discount rates relevant to Zentalis Pharmaceuticals.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for Zentalis Pharmaceuticals, Inc. (ZNTL).
  • Visual Dashboard and Charts: Graphical representations summarize essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review the pre-entered Zentalis Pharmaceuticals data (historical and projected).
  3. Step 3: Modify key assumptions (yellow cells) based on your analysis.
  4. Step 4: Observe automatic recalculations for Zentalis Pharmaceuticals’ intrinsic value.
  5. Step 5: Utilize the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • Accuracy: Utilizes real Zentalis Pharmaceuticals financials to guarantee data precision.
  • Flexibility: Crafted for users to easily test and adjust inputs as needed.
  • Time-Saving: Eliminate the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Designed with CFO-level accuracy and user experience in focus.
  • User-Friendly: Intuitive interface, suitable for individuals without extensive financial modeling skills.

Who Should Use Zentalis Pharmaceuticals, Inc. (ZNTL)?

  • Pharmaceutical Investors: Make informed investment choices with our cutting-edge research and insights.
  • Healthcare Analysts: Streamline your analysis with comprehensive reports on drug development and market potential.
  • Consultants: Easily modify our findings for client briefings or strategic recommendations.
  • Biotech Enthusiasts: Enhance your knowledge of pharmaceutical advancements and industry trends.
  • Academics and Students: Utilize our resources as a valuable educational tool in pharmaceutical and business studies.

What the Template Contains

  • Pre-Filled DCF Model: Zentalis Pharmaceuticals’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Zentalis Pharmaceuticals’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.